Butabarbital and olopatadine intranasal both boost sedation. Avoid or Use Alternate Drug. Coadministration improves hazard of CNS depression, which may lead to additive impairment of psychomotor performance and bring about daytime impairment. butabarbital will lower the level or effect of midazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Butabarb... https://rolimm098afj4.nizarblog.com/profile